Pritesh Gandhi

Pritesh Gandhi's work experience includes various leadership roles in the pharmaceutical and healthcare industry. Pritesh is currently the Chief Executive Officer at TellBio, Inc., a diagnostics and therapeutics platform company focused on cancer treatment. Prior to this, they worked at Alnylam Pharmaceuticals as the General Manager, overseeing end-to-end project decisions and leading the late-stage program. Pritesh also served as the Vice President of Medical Affairs at Alnylam, where they developed strategic plans and collaborated with clinical research and operations for clinical trial strategies. Before joining Alnylam, Pritesh held positions at Sanofi, where they were responsible for global priorities in publications, medical education, and medical communications. Pritesh also worked at Alexion Pharmaceuticals, Millenium Pharmaceuticals, UMass Medical School, Massachusetts College of Pharmacy and Health Sciences, and the University of Illinois at Chicago, gaining expertise and experience in cardiovascular pharmacotherapy, pharmacy practice, and residency programs.

Pritesh Gandhi completed their Doctor of Pharmacy (PharmD) degree from the Massachusetts College of Pharmacy and Health Sciences from 1991 to 1997. Afterward, in 1997-1998, they pursued a Pharmacy Practice Residency at the University of Illinois Chicago.